ArticleThoracic cancer2023

Study protocol of KeyPemls-004: A phase 2 study of pembrolizumab in combination with plinabulin and docetaxel in previously treated patients with metastatic non-small cell lung cancer and progressive disease (PD) after immunotherapy (PD-1/PD-L1 inhibitor) alone or in combination with platinum-doublet chemotherapy.

Jia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.